ClinicalTrials.gg
CompletedNCT05629312Updated Mar 26, 2025Results posted

Effect of Interceptive Strategies on the Clinical Outcome of Maxillary Impacted Canines

An interventional study of Maxillary expansion and Extraction of deciduous upper canines in Tooth, Impacted, sponsored by Universitaire Ziekenhuizen KU Leuven. Completed at 1 site in Belgium. Open to participants aged 7 Years to 11 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-03-26.

Sponsored by Universitaire Ziekenhuizen KU Leuven · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 6 years 2 months after the study started (first participant enrolled Sep 2016, registered Nov 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
84
Allocation
Randomized
Ages
7 Years to 11 Years
Sex
All
01

Study summary

This study aims to investigate the effect of 3 randomly applied interceptive measures (slow maxillary expansion, extraction of deciduous canines and no intervention) on maxillary canine impaction in patients with early mixed dentition and lack of space in the dental arch. Additionally, these groups are compared with a control group with adequate space. Patients with at least one impacted maxillary canine, presence of deciduous canines and absence of crossbite were included. The canine position is assessed by measuring five variables (sector of the canine cusp, canine to midline angle, canine to first premolar angle, canine cusp to midline distance, and canine cusp to maxillary plane distance) on 2 panoramic radiographs at 0 (T1) and 18 months (T2).

Read the detailed description

The detailed information regarding methodology has been entered in following sections

02

Conditions studied

  • Tooth, Impacted

Browse trials for

Keywords

  • Interceptive orthodontics
  • maxillary canines
  • maxillary expansion
  • Tooth extraction
  • deciduous tooth
03

In context

Tooth, Impacted

122 studies on the registry are indexed under Tooth, Impacted; 15 are open to participants now.

This study's enrollment of 84 is above the median of 70 across 88 interventional studies indexed under Tooth, Impacted.

Browse Tooth, Impacted studies →

Lead sponsor

Universitaire Ziekenhuizen KU Leuven is the lead sponsor of 963 studies on the registry; 267 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 11 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All patients presenting at the intake consultation of the Department of Orthodontics of University Hospitals Leuven, Belgium from September 2016, with at least one maxillary permanent canine impaction are invited to participate. Canine impaction is diagnosed based on a panoramic radiograph, taken for standard evaluation of dental development and associated pathology. A maxillary canine is considered to be impacted when the canine to midline angle was ≥15° (Alqerban et al. 2014; Warford et al. 2003). Only impacted maxillary canines with incomplete root formation and with persisting deciduous canines are included.

Exclusion criteria

Exclusion Criteria:

  • presence of uni- or bilateral posterior dental crossbite,
  • upper permanent canines showing root malformation, ankylosis or fully erupted,
  • evidence of root resorption of adjacent teeth, previous orthodontic treatment,
  • craniofacial syndromes,
  • systemic disease that would impede orthodontic treatment/surgery and recent exposure to radiotherapy.
  • large eruption follicles seen on the permanent canines
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
84 participants (actual)

Study arms

  • Experimental
    Maxillary expansion

    All included patients (in all arms) present (at least one) maxillary canine impaction. Patients in this arm present also lack of space in the upper jaw and are treated with maxillary expansion

    Procedure: Maxillary expansion

  • Experimental
    Extraction of deciduous canines

    All included patients (in all arms) present (at least one) maxillary canine impaction. Patients in this arm present also lack of space in the upper jaw and are treated with extraction of deciduous canines

    Procedure: Extraction of deciduous upper canines

  • No intervention
    No intervention

    All included patients (in all arms) present (at least one) maxillary canine impaction. Patients in this arm present also lack of space in the upper jaw and no intervention is performed

  • No intervention
    Control

    All included patients (in all arms) present (at least one) maxillary canine impaction. Patients in this arm do not present lack of space in the upper jaw and no intervention is performed

Interventions

  • ProcedureMaxillary expansion

    The upper jaw is expanded with a removable expansion plate

  • ProcedureExtraction of deciduous upper canines

    Both deciduous upper canines are extracted in this group

06

What researchers measure

Primary outcomes

  1. Number of Definitive Upper Canines That Erupt Spontaneously up to 18 Months of Follow up

    Number of definitive upper canines that erupt spontaneously up to 18 months of follow up.

    Time frame: 18 months

  2. Number of Definitive Upper Canines That Erupt Spontaneously After 18 Months of Follow up

    Number of definitive upper canines that erupt spontaneously after 18 months of follow up..

    Time frame: After the first 18 months of follow up

Secondary outcomes

  1. Sector Where the Canine is Located

    The sector is the position where the canine overlaps with adjacent teeth in a panoramic radiograph. The distance between the dental midline and the premolars is divided in 5 equally large spaces (units or categories 0 to 4) defined as follows: 0 = normal position (the cusp of the definitive canine is at the primary canine), 1 = distal to the long axis of the lateral incisor, 2 = mesial to the long axis of the lateral incisor, 3 = distal to the long axis of the central incisor, or 4 = mesial to the long axis of the central incisor This outcome measurement refers to the change in the Sector category where the canine is located, measured on a panoramic RX

    Time frame: 18 months

  2. Angulation of the Canine Towards the Dental Midline

    Change in the Angulation of the canine towards the dental midline, measured on a panoramic RX

    Time frame: 18 months

  3. Angulation of the Canine Towards the First Premolar

    Change in the Angulation of the canine towards the first premolar

    Time frame: 18 months

  4. Distance Between the Canine Cusp and the Midline

    Change in the Distance between the canine cusp and the midline

    Time frame: 18 months

  5. Distance Between the Canine Cusp and the Occlusal Plane

    Chenge in the Distance between the canine cusp and the occlusal plane, measured on a

    Time frame: 18 months

  6. Need for Further Minor and/or Major Orthodontic Intervention

    Need for further minor and/or major orthodontic interventions

    Time frame: 18 months after baseline

07

Results

Posted Mar 26, 2025

Participant flow

Participant flow — Overall Study
MilestoneMaxillary ExpansionExtraction of Deciduous CaninesNo InterventionControl
Started22181628
Completed19171426
Not completed3122

Outcome measures

PrimaryNumber of Definitive Upper Canines That Erupt Spontaneously up to 18 Months of Follow up

Number of definitive upper canines that erupt spontaneously up to 18 months of follow up.

Time frame:
18 months
Reported as:
Number · number of canines
Number of Definitive Upper Canines That Erupt Spontaneously up to 18 Months of Follow up
number of caninesMaxillary ExpansionExtraction of Deciduous CaninesNo InterventionControl
Number of Definitive Upper Canines That Erupt Spontaneously up to 18 Months of Follow up3214
PrimaryNumber of Definitive Upper Canines That Erupt Spontaneously After 18 Months of Follow up

Number of definitive upper canines that erupt spontaneously after 18 months of follow up..

Time frame:
After the first 18 months of follow up
Reported as:
Number · number of canines
Number of Definitive Upper Canines That Erupt Spontaneously After 18 Months of Follow up
number of caninesMaxillary ExpansionExtraction of Deciduous CaninesNo InterventionControl
Number of Definitive Upper Canines That Erupt Spontaneously After 18 Months of Follow up44615
SecondarySector Where the Canine is Located

The sector is the position where the canine overlaps with adjacent teeth in a panoramic radiograph. The distance between the dental midline and the premolars is divided in 5 equally large spaces (units or categories 0 to 4) defined as follows: 0 = normal position (the cusp of the definitive canine is at the primary canine), 1 = distal to the long axis of the lateral incisor, 2 = mesial to the long axis of the lateral incisor, 3 = distal to the long axis of the central incisor, or 4 = mesial to the long axis of the central incisor This outcome measurement refers to the change in the Sector category where the canine is located, measured on a panoramic RX

Time frame:
18 months
Reported as:
Mean · Change in sector unit
Sector Where the Canine is Located
Change in sector unitMaxillary ExpansionExtraction of Deciduous CaninesNo InterventionControl
Sector Where the Canine is Located-0.22 (-0.43 to -0.01)-0.15 (-0.33 to 0.03)0.11 (-0.22 to 0.43)-0.10 (-0.23 to 0.02)
SecondaryAngulation of the Canine Towards the Dental Midline

Change in the Angulation of the canine towards the dental midline, measured on a panoramic RX

Time frame:
18 months
Reported as:
Mean · Degrees
Angulation of the Canine Towards the Dental Midline
DegreesMaxillary ExpansionExtraction of Deciduous CaninesNo InterventionControl
Angulation of the Canine Towards the Dental Midline-11.85 (-15.99 to -7.71)-8.16 (-13.19 to -3.13)-7.68 (-13.76 to -1.60)-11.29 (-15.06 to -7.52)
SecondaryAngulation of the Canine Towards the First Premolar

Change in the Angulation of the canine towards the first premolar

Time frame:
18 months
Reported as:
Mean · Degrees
Angulation of the Canine Towards the First Premolar
DegreesMaxillary ExpansionExtraction of Deciduous CaninesNo InterventionControl
Angulation of the Canine Towards the First Premolar-2.27 (-5.92 to 1.38)-3.13 (-6.78 to 0.53)0.08 (-4.70 to 4.86)-2.57 (-6.88 to 1.73)
SecondaryDistance Between the Canine Cusp and the Midline

Change in the Distance between the canine cusp and the midline

Time frame:
18 months
Reported as:
Mean · millimeters
Distance Between the Canine Cusp and the Midline
millimetersMaxillary ExpansionExtraction of Deciduous CaninesNo InterventionControl
Distance Between the Canine Cusp and the Midline0.83 (-0.58 to 2.24)0.57 (-0.65 to 1.80)-0.51 (-2.21 to 1.19)1.77 (0.14 to 3.41)
SecondaryDistance Between the Canine Cusp and the Occlusal Plane

Chenge in the Distance between the canine cusp and the occlusal plane, measured on a

Time frame:
18 months
Reported as:
Mean · millimeters
Distance Between the Canine Cusp and the Occlusal Plane
millimetersMaxillary ExpansionExtraction of Deciduous CaninesNo InterventionControl
Distance Between the Canine Cusp and the Occlusal Plane-6.31 (-9.82 to -2.80)-4.79 (-6.87 to -2.71)-7.10 (-10.78 to -3.43)-9.14 (-11.78 to -6.51)
SecondaryNeed for Further Minor and/or Major Orthodontic Intervention

Need for further minor and/or major orthodontic interventions

Time frame:
18 months after baseline
Reported as:
Count of participants · Participants
Need for Further Minor and/or Major Orthodontic Intervention
ParticipantsMaxillary ExpansionExtraction of Deciduous CaninesNo InterventionControl
Minor intervention8205
MAjor intervention4972

Adverse events

Collected over 3 years (18 months during trial period, 18 months after trial period). Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Maxillary Expansion0/19 (0%)0/19 (0%)0/19 (0%)
Extraction of Deciduous Canines0/17 (0%)0/17 (0%)0/17 (0%)
No Intervention0/14 (0%)0/14 (0%)0/14 (0%)
Control0/26 (0%)0/26 (0%)0/26 (0%)

Baseline characteristics

Information not different to that of Participant Flow

Age, Categorical
Age, Categorical(Participants)Maxillary ExpansionExtraction of Deciduous CaninesNo InterventionControlTotal
<=18 years1917142676
Between 18 and 65 years00000
>=65 years00000
Age, Continuous
Age, Continuous(years)Maxillary ExpansionExtraction of Deciduous CaninesNo InterventionControlTotal
Mean8.9 ± 1.169.1 ± 1.469.0 ± 1.239.7 ± 1.449.2 ± 1.32
Sex: Female, Male
Sex: Female, Male(Participants)Maxillary ExpansionExtraction of Deciduous CaninesNo InterventionControlTotal
Female1186530
Male8982146
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Maxillary ExpansionExtraction of Deciduous CaninesNo InterventionControlTotal
Hispanic or Latino00000
Not Hispanic or Latino00000
Unknown or Not Reported1917142676
Region of Enrollment
Region of Enrollment(Participants)Maxillary ExpansionExtraction of Deciduous CaninesNo InterventionControlTotal
Belgium1917142676
08

Study locations

1 site
  • UZ Leuven
    Leuven, Vlaams Brabant 3000, Belgium
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2016 to primary completion in Oct 2023, 85 months.

Results were first posted in Mar 2025, 1 year 4 months after primary completion.

Of 55 non-industry interventional studies with no phase under Tooth, Impacted, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 35. This study's 85 months is above that.

Counting every sponsor, half of 56 studies reached it within 20 months; a quarter within 8 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 16, 2022
First posted
Nov 29, 2022
StartActual
Sep 12, 2016
Primary completionActual
Oct 30, 2023
CompletionActual
Oct 30, 2023
Results first posted
Mar 26, 2025
Last update
Mar 26, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05629312
Responsible party
Sponsor
First posted
Nov 29, 2022
Start date
Sep 12, 2016
Primary completion
Oct 30, 2023
Completion
Oct 30, 2023
Results posted
Mar 26, 2025
Last update
Mar 26, 2025

Study contacts

Maria Cadenas
principal investigator · UZ Leuven

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion